INTRODUCTION

Scope
The physiological mechanisms by which various hypersensitivity phenomena manifest themselves are poorly understood. Presumably, the various types of hypersensitivity reactions result from either a systemic or localized release of pharmacological agents. The specific pharmacologic agents involved in allergic or hypersensitivity reactions are known with some certainty for only a few animal species. Histamine is of great importance in anaphylaxis of the guinea pig and rabbit, and serotonin has been implicated in the mouse and in the rat. Other pharmacological agents have also been implicated in hypersensitivity reactions, such as the "slow reacting substance," bradykinin, acetylcholine, and others less well known. Histamine, by far, has been best studied. It is a potent, naturally occurring amine known to produce vasodilatation, promote capillary permeability, and induce bronchoconstriction. Marked differences in susceptibility to histamine exist among animal species. Guinea pigs and rabbits are highly susceptible to the lethal effect of histamine, whereas mice and rats have a remarkable tolerance to it (Table 1) . It has been known for several years that the tolerance of at least some strains of rats and mice can be greatly diminished by administering certain bacterial substances. An understanding of how these substances sensitize animals to histamine would increase our knowledge of hypersensitivity in general. This review attempts to summarize the present knowledge of bacterial substances which have been reported to enhance sensitivity of animals to histamine.
Most of the observations in this field have been made with cells from smooth cultures of Bordetella pertussis or with extracts therefrom. The literature dealing with other microorganisms consists mainly of isolated observations on histamine sensitization produced in animals. Little or no work has been reported on the mode of action and the purification of the sensitizing substances from microorganisms other than B. pertussis. This review covers various aspects of the histamine sensitization phenomenon, and discusses the relationship of this sensitization to other phenomena associated with the treatment of animals with histamine-sensitizing materials. The nature of the substances producing sensitization and the various postulated mechanisms of action of these intriguing substances will be also discussed.
Reviews have appeared which cover various aspects of this topic (71, 100, 107, 152, 154, 205, 217, 223) . The present review will emphasize recent advances and topics not well covered previously.
Historical Notes Eldering (45) was the first to report that treatment with fractions from B. pertussis increased the susceptibility of mice to intraperitoneal challenge with living cells of B.pertussis. Similar phenomena were observed later with whole-cell vaccine as toxin. This reaction was most probably an anaphylactic shock, although it was not recognized as such by Ospeck and Roberts. Parfentjev et al. (186) (187) (188) observed a similar phenomenon when they found that mice pretreated with pertussis vaccine died after receiving a denatured nucleoprotein isolated from B. pertussis. This sensitivity was considered to have an immunological basis, but it was not clearly recognized as being associated with anaphylactic shock until Malkiel and Hargis described their observations on the increased susceptibility of B. pertussis-treated mice and rats to actively induced anaphylaxis (121) (122) (123) (124) . These observations have been confirmed and extended by various workers employing a variety of antigens (100, 154, 205, 223) . Furthermore, B. pertussis-treated mice were also seen to become more susceptible to passively induced anaphylaxis (156, 169, 206 ; J. Munoz, L. F. Schuhardt, and W. F. Verwey, Federation Proc. 13:507, 1954 ). The observations of Parfentjev et al. (186) (187) (188) that B. pertussis-treated mice become sensitive to a denatured nucleoprotein preparation from B. pertussis led these workers to test the sensitivity of B. pertussis-treated mice to histamine. They found that pertussis vaccine increased the susceptibility of their mice to histamine up to 100-fold (185) . This observation was soon confirmed (79, 94, 102, 202, 229) . Ten years after Parfentjev and Goodline's (185) discovery of histamine sensitization in mice, it was shown that some strains of mice also become hypersensitive to serotonin after treatment with pertussis vaccine (89, 98, 150, 205) . This observation was considered to be of further significance because serotonin had been implicated in mouse anaphylaxis (55, 67, 232) .
The above observations established at least three recognizable and seemingly distinct effects produced by killed B. pertussis cells in mice: (i) an increase in susceptibility to infection, (ii) an increase in susceptibility to anaphylaxis, and (iii) an increase in susceptibility to histamine and serotonin. We should mention that an increase in resistance to infection (44, 191) and to tumor growth (129) has also been observed under certain conditions in mice treated with B. pertussis. This resistance-inducing factor is probably similar to endotoxin from other gram-negative bacteria and different from the factor responsible for increased susceptibility to histamine, serotonin, and perhaps to other agents. Ample confirmatory evidence regarding the effect of the histamine-sensitizing factor (HSF) from B. pertussis is now found in the literature (71, 100, 119, 152, 154, 205, 217, 223) .
Pertussis vaccine produces many other changes in mice, which may or may not be due to the same substance that produces histamine sensitization. It is not known whether these changes are produced by a common mechanism or whether they develop from a variety of effects produced by pertussis vaccine.
HISTAMINE-SENSITIZING PROPERTIES OF VARIOUS BACTERIA
The criterion for histamine sensitization that has been used almost exclusively is the increased lethal effect of histamine in mice or rats treated with histamine-sensitizing factors. A few workers have employed reactivity of the skin (215, 216) or symptoms of shock induced by this amine (106) to measure increased sensitivity to histamine. [80) , and even phase IV B. pertussis (80, 94) . When endotoxins extracted from many of these organisms were tested for their ability to produce histamine sensitization, however, some sensitization in mice was obtained (130, 196) . This sensitization was inferior to that produced by B. pertussis, and, in addition, large amounts of endotoxin were needed, in many cases approaching the lethal dose of these lipopolysaccharides (Table 2 ). Malkiel and Hargis (130) , for example, found that the intraperitoneal doses (100 to 200 Mug) which induced histamine sensitivity were invariably lethal when given intravenously. Pieroni et al. (196) (9, 10, 46-49, 209, 219) , but various workers believe that HSF is identical to the mouse-protective antigen (86, 111, 161, 195) . Others feel that HSF and mouseprotective antigen are two distinct substances (43, 170, 218, 227) .
Soluble preparations of HSF have been obtained from culture supernatant fluids (74, 118, 119, 172) , from sonically disrupted cells (51, 119, 239) , from cells dissolved with sodium deoxycholate (17, 42, 237) , from cells treated with lysozyme (15, 16, 139, 211) , by extraction of cells with a mixture of thiourea-urea and formamide (76, 118) , by autolysis (119) , and from acetone-dried cells extracted with alkaline saline (160, 161 The ammonium sulfate-precipitated materials contain not only HSF but also protective activity, and indeed many of the activities found in the whole cell (195, 197, 198, 200) . Levine and Pieroni (111) have strongly suggested that all of these activities are due to the same substance. Although this is probable from some of the results that have been obtained (160, 161, 195, (197) (198) (199) (200) , it is still premature to assign most of the reactions observed with whole cells, or with relatively crude extracts, to a single molecular entity.
Recently, two groups have published observations regarding the separation of HSF from protective activity. Both claimed to have separated the two activities, one by sucrose density gradient centrifugation of soluble starting materials (218) , and the other by centrifugation at 4 C for 2 hr at 60,000 x g of sodium deoxycholate lysates of B. pertussis (170) . Sato and Nagase (218) The activity of HSF is destroyed by heat (80 C for 0.5 hr) (8, 90, 97, 119, 162, 172) , by Formalin (88, 91, 136, 162) , and by some proteolytic enzymes such as trypsin [Sutherland (227) did not obtain destruction by trypsin], Pronase, and a protease from Bacillus subtilis (82, 107, 138, 195) . Deoxyribonuclease, ribonuclease (237) , lysozyme (15, 16, 139, 211) , lipase, cellulase, and amylase (238) do not destroy it.
The activity is always found in fractions containing high concentrations of nitrogen (160, 161, 170, 195) , and our saline extract preparations and MgSO4-precipitated material have an almost full complement of amino acids, except cysteine and methionine (J. Munoz and B. Hestekin, Federation Proc., p. 267, 1968) . The absence of these two amino acids has also been noted by Hiramatsu (82) . HSF is only slowly inactivated by NaIO4, suggesting that HSF does not depend on carbohydrate for its activity (82, 238, 239 (82) . Some HSF sediments quickly, but as much as 16 hr at 125,000 X g is required to sediment all the activity (J. Munoz, unpublished data). At higher purity, the sedimentation pattern of HSF could change completely, because it becomes less soluble in saline. Purified HSF preparations made by MgSO4 precipitation are rather insoluble, although they can be solubilized in the presence of sodium deoxycholate or sodium lauryl sulfate. The latter is more efficient, but it also causes faster deterioration of the HSF activity.
The purified HSF retains a certain amount of toxicity, although this is low and requires about 1,000 ,ug given intraperitoneally to kill mice and the same amount given intravenously to kill rabbits (152; J. Munoz and B. M. Hestekin, Federation Proc. 27:267, 1968). Purified preparations contain little or no endotoxin, since they fail to elicit a Shwartzman reaction, to produce fever in rabbits, or to kill chick embryos in doses which are much higher than those of endotoxin required 80, 1957) . High alkalinity (pH 10 to 11) or high acidity (pH 1 to 2) destroys the activity (Niwa, personal communication) .
HSF is antigenic, and neutralizing antibodies can be produced (118, 119) . However, most antisera to B. pertussis cells seem to have little or no antibody to HSF. In most cases, antisera fail to neutralize the activity of soluble preparations of HSF, although they neutralize the activity of whole cells (J. Munoz, Federation Proc. 23:404, 1964) . Moreover, some workers have reported that whole cells treated with antiserum and subsequently washed still sensitize mice to histamine (38, 193) . Recently, we have produced antisera with purified HSF, which react specifically with it and neutralize its activity. The neutralization observed in many laboratories with most hyperimmune sera to B. pertussis might have been due to antibodies to surface antigens which coat the bacterial cells and thus render them more easily phagocytized and perhaps prevent the active material from reaching the sites in which the HSF acts.
Our purest preparations of HSF have always exhibited not only histamine-and serotoninsensitizing properties, but also protective activity against intracerebral challenge with B. pertussis. They have also had the anaphylactogenic effect, the adjuvant effect, and have promoted the increased disappearance of Evans blue from the circulation. For these reasons, we have suspected, as did Levine and Pieroni (111) , that these activities reside in the same molecule. Further purification of HSF is required to settle this point.
The only other substances that, to our knowledge, have been characterized and that have been reported to produce histamine sensitization are the endotoxins of gram-negative organisms. Since the nature of these substances has been extensively studied and it is still doubtful whether or not endotoxin has a primary histamine-sensitizing action, they will not be discussed in this review. Those interested in learning about the methods of purification and characterization of endotoxins should consult the various reviews and symposia on these interesting substances (e.g., 108).
CHARACTERISTICS OF SENSMZATION
TO HISTAMINE Animal species differ widely in their sensitivity to the lethal effects of histamine (Table 1) . Mice and rats are highly resistant, whereas guinea pigs and rabbits are highly susceptible. The effects of the histamine-sensitizing substance from B. pertussis have been demonstrated mainly in animals that are highly resistant to doses of histamine, because death has been used as the main criterion of sensitization. Mice become 50 to 100 times more sensitive after treatment with HSF; the increase is of a lower order in rats (32, 124, 185) . Other animals have not been thoroughly investigated with respect to histamine sensitization by HSF. Guinea pigs and rabbits may become, if anything, more resistant to histamine after injection of B. pertussis vaccine (119, 226) . One report (106) indicates that guinea pigs, rats, and mice become more susceptible to histamine after injection of avirulent P. pestis cells or cell autolysates, but, as stated above, this work was not extensive and confirmation is required. Sanyal (215) observed an increased skin sensitivity to histamine in children with whooping cough. Mathov (133) reported a slight increase in skin sensitivity to histamine in children vaccinated with pertussis vaccine, but the observed increase was not statistically significant.
Marked differences in the susceptibility of mouse strains to the sensitizing effects of HSF have been reported (Table 4) . Some strains, mainly those derived from the Swiss-Webster line, are highly susceptible to the histaminesensitizing effects of HSF, but many other strains, including various inbred strains, are rather resistant (23, 154) . Recent work in our laboratory (24) , however, indicates that HSF produces an effect in most mouse strains (inbred or noninbred), when sensitivity is tested with a combination of histamine and serotonin (Table  4) . Some strains, such as the SW-55 (85) and the CFW mice (C. W. Fishel, personal communication), have been found normally sensitive to a combination of serotonin and histamine. Some strains of mice become sensitive to serotonin and not to histamine (23, 150) , indicating that the importance of these two amines varies in different mouse strains. Marked differences in susceptibility to sensitization to histamine after administration of HSF have also been noted in the same strain of mouse raised in different laboratories (J. Munoz and R. K. Bergman, unpublished data).
Whole-cell vaccines given intraperitoneally produce an increasing sensitization to histamine during the first 4 days. At this time, sensitization 159. have been considered resistant to histamine sensitization are somewhat sensitive to histamine when histamine LD50 values are determined (19) . HSF produces sensitization to histamine plus serotonin challenge in most strains; only a few strains become sensitive to histamine or serotonin given alone (Table 4) .
Within mouse strains that become sensitive to histamine, the female mouse is usually found to be more sensitive than the male to histamine and to sensitization by B. pertussis vaccine (119, 202) . This difference in response between sexes was not found by Kind (94) in individual experiments, but our experience, like that of Pittman (202) The sensitivity of mice to histamine is affected by still other factors, the identity of which is not well known. During the past year, we tested the normal sensitivity of CFW female mice (6 to 7 weeks old, 22 to 24 g body weight) approximately 4 days after they arrived at our laboratory from New York. The results of this survey are illustrated in Fig. 3 . It is clear that these mice vary markedly from shipment to shipment in their sensitivity to 0.5 mg of histamine, when they are tested after the stress of shipment. Since dehydration may increase the sensitivity to histamine (208) (Fig.  4) . The route of choice with whole cells or soluble extracts is the intravenous route (119, 159) . Some workers have also found the intracranial route to be highly effective (87) . Intranasal infection with B. pertussis also induces histamine sensitization (204) . Treatment of mice with many different substances (aspirin, propylene glycol, etc.) during the period between sensitization with B. pertussis cells and challenge with histamine changes the dose response to histamine from one in which increasing doses of histamine produce correspondingly increased mortality, to one in which greater mortality is obtained at lower doses (0.2 to 2 mg of histamine) than at relatively higher doses (4 to 8 mg) (166) . This phenomenon is as yet unexplained, but might be due to a "triggering" action of a critical concentration of histamine on epinephrine release. Mild stress may similarly modify the dose response to histamine. On the other hand, severe and prolonged stress may, by producing adrenal exhaustion, make mice more sensitive to histamine.
Injection of Formalin-treated extract from B. pertussis, given some days before the sensitizing dose of pertussis vaccine, inhibits sensitization to histamine by a second active dose of cells (136 that they change a fundamental physiological function normally involved in protecting against the toxic effects of many substances that kill the animal through some form of shock. The isolated uterus or intestine of the B. pertussis-treated mouse does not show an increased reactivity to histamine or anaphylaxis (56, 163) , and the skin is not more reactive to passive cutaneous anaphylaxis (157) . The B. pertussis-treated rat becomes more sensitive to histamine and anaphylaxis (124) , to some cutaneous hypersensitivity reactions (214) , and to the development of nephritis when homologous kidney extracts are given with B. pertussis vaccine (29) . The skin sensitivity of the rat to histamine or serotonin is not modified (214) . In this connection, it should be mentioned that endotoxin from gram-negative bacteria has been shown to increase the reactivity of the isolated guinea pig uterus to histamine in an entirely in vitro system (236) . The endotoxin must be present in the tissue bath to exert this effect.
One prominent feature of pertussis vaccine is its ability to increase anaphylactic sensitivity of mice (121, 188) . Although B. pertussis has the ability to increase antibody production to a given antigen (13, 14, 31, 52, 61, 72, 73, 99, 126, 153, 178, 235) , this effect only partially explains the anaphylactogenic effect, because pertussis vaccine also increases the susceptibility to passive anaphylaxis. In the latter case, antibody formation is not involved, and, thus, differences in antibody titers can be minimized (156, 169, 206) . The increased sensitivity to passive anaphylaxis is most pronounced in the early stages after administration of B. pertussis. This sensitivity seems to be increased for only about 5 days after B. pertussis injection (169) . With actively induced anaphylaxis, the increase can be noticed from the 7th to 10th days and persists for at least 77 days (154) (Fig. 1) . Sensitivity to actively induced anaphylaxis is also increased by various adjuvants (126, 153, 225) (28, 147, 149) . This antibody is different from the 7S-y1 globulin, which produces PCA in mice but disappears from the skin site 24 hr after its administration (147, 157, 177) . This property of B. pertussis of selectively stimulating the formation of one type of antibody during the early period after immunization may partly explain the anaphylactogenic effect of B. pertussis cells in actively sensitized mice. However, it does not explain the increased sensitivity to passive anaphylaxis. In this case, the increase in susceptibility must be due to a mechanism similar to that which induces sensitization to other substances, such as histamine, serotonin, peptone, bradykinin, X ray, and endotoxin. It should be emphasized that the state of hypersensitivity to histamine or serotonin produced by HSF is not necessary for the increased sensitivity to either passive or active anaphylaxis in the mouse (154) . Fatal active anaphylaxis can, for example, be observed at a time when sensitivity to the amines has greatly diminished. Fatal passive anaphylaxis cannot be observed 2 to 3 weeks after HSF administration when high sensitivity to histamine and serotonin exists.
Many other physiological changes have been observed in B. pertussis-treated mice (Table 6 ). One effect of B. pertussis vaccine, which may be related to the histamine-sensitizing factor, is acceleration of production of experimental allergic encephalomyelitis (EAE) in mice (109) and rats (112) (113) (114) (115) . This effect is observed when the encephalitogenic material is given in Freund's adjuvant containing B. pertussis instead of mycobacteria (117, 224, 240) or when pertussis vaccine is mixed in an aqueous suspension with the encephalitogenic antigen. Moreover, the encephalitogenic material can be given simultaneously with pertussis vaccine or several days after the administration of the vaccine (109, (112) (113) (114) . It is noteworthy that adrenalectomy also makes rats more susceptible to EAE (116) . The effect of pertussis vaccine on EAE in rats has been studied in some detail by Levine et al. (112) (113) (114) (115) . They have found that B. pertussis cells given with an aqueous suspension of the encephalitogenic antigen produce an accelerated disease which has a different histological character, inasmuch as many polymorphonuclear cells, edema fluid, and accumulated fibrin are present in the perivascular exudates. This form of hyperacute EAE has also been produced by partially purified HSF made in our laboratory and elsewhere (115) . The activity is destroyed by heating HSF at 80 C for 0.5 hr or by treatment with Formalin. Moreover, all active fractions tested also contained the histamine-sensitizing substance. Endotoxin from E. coli, S. typhosa, or B. pertussis does not induce hyperacute EAE (115) . The mechanism by which this phenomenon is produced is not yet clear.
In human infection with B. pertussis, one of the prominent features is development of a pronounced leukocytosis, accounted for by an absolute increase in the lymphocytes (64) . Killed pertussis vaccine also produces lymphocytosis in man (219) and in experimental animals (7, 30, 39, 50, 53, 141, 234) (141) . Pertussis vaccine also has an accelerating effect on the growth of lymphomas in mice (62, 83) .
Fichtelius and Hassler (54) observed that injection ol pertussis vaccine into adrenalectomized rats, maintained on mineralocorticoids, stimulated production of lymphocytes at a faster rate than in adrenalectomized unvaccinated controls. The increase in lymphocytes is first noticed 1 day after intravenous inoculation of pertussis vaccine, and maximal response is reached 4 days later (141) . Leukocyte and lymphocyte populations return to normal by the 14th day. The number of polymorphonuclear leukocytes also increases after B. pertussis treatment, but the most important change, by far, occurs in the small lymphocytes. The number of large lymphocytes and monocytes does not change significantly. The intravenous route of treatment is the most effective, followed by the intraperitoneal route; the subcutaneous route is ineffective in producing lymphocytosis (141) . The time course and the effect of route of injection of B. pertussis cells are strikingly similar to the histamine-sensitization phenomenon in that maximal sensitization is reached at about 4 days, and subcutaneous injection of whole-cell vaccines is also ineffective (119, 132; J. Munoz, Federation Proc. 23:404, 1964 ). The substance producing the leukocytosis is heat-labile and is found in soluble alkaline saline extracts (C. Clausen, unpublished data). Some of the properties of the lymphocytosis factor are similar to HSF, and the factor does not appear to be related to endotoxin. Since the increase in lymphocytes is accompanied by a depletion of small lymphocytes from lymph nodes and thymus, with no obvious increase in multiplication of the lymphocytes, Morse and Riester (143, 144) believe that the lymphocytosis is due to shifting of the lymphocyte circulation. Splenec-tomy or thymectomy does not prevent the lymphocytic response after B. pertussis vaccine, but active and passive immunization of mice against B. pertussis prevents or markedly reduces the leukocytic response (141) . Mice rendered lymphocytopenic by X irradiation or by administration of hydrocortisone still show lymphocytosis and granulocytosis (142) . Histamine sensitization in mice does not require the presence of leukocytosis, since histamine sensitivity lasts beyond the period of leukocytosis, and antileukocyte serum that markedly reduces leukocytosis does not affect histamine sensitivity (C. Clausen, unpublished data). These observations do not show that the HSF and the leukocytepromoting substances are different, but rather that the two phenomena are independent of each other.
A number of metabolic changes have been observed in mice treated with pertussis vaccine (Table 6 ). HSF-treated mice exhibit a marked hypoglycemia (190, 226) , and some investigators have thought that sensitization to histamine and other agents is a consequence of the hypoglycemia (71) . Alloxan diabetes induced in HSF-treated mice protects them from histamine death, and the protective effect is diminished by insulin treatment (65, 230, 231 ; 0. H. Ganley and H. J. Robinson, Federation Proc. 18:392, 1959 ). It has also been noticed that the blood levels of insulin are increased in HSF-treated mice (A. Gulbenkian and also C. W. Fishel, personal communications). Pertussis vaccine-treated mice show an altered glucose tolerance which is manifested by failure of an intravenous dose of 0.5 mg of glucose per g of body weight to produce a rise in blood glucose (58) . Normal mice similarly treated show a pronounced rise. Pertussis vaccine-treated mice and rats also fail to show the hyperglycemic response after release of endogenous epinephrine or after treatment with exogenous epinephrine (58, 77, 228) . Moreover, epinephrine administered to HSF-treated mice does not reduce the tissue uptake of glucose (58) . Pertussis-treated mice also fail to respond to catecholamines with an elevated level of lactic acid and free fatty acids, although the effect of catecholamines on liver glycogen is not reduced (92) . All these effects on sugar and fatty acid metabolism may be of great significance in the phenomena of sensitization induced by pertussis vaccine; however, interpretation is still difficult.
Another physiological change noticed in mice receiving HSF is a significant hypoproteinemia which persists for several days and is apparently due to a depressed albumin level. Administration of exogenous albumin or whole serum has not been effective in restoring the depressed protein level or in protecting mice from death after histamine challenge (R. K. Bergman and J. Munoz, in preparation).
When HSF-treated mice and untreated mice are given equal doses of Evans blue dye intravenously, the HSF-treated mice have, 20 min to 4 hr later, a lower dye concentration in their serum than the controls. This was interpreted to indicate an increased capillary permeability to the dye in HSF-treated mice (151) . The finding that HSF produces a hypoalbuminemia casts some doubt on this interpretation, because Evans blue dye readily combines with albumin to form a complex which remains in the circulation for a long period of time. If the capillaries are freely permeable to unbound dye and the quantity of dye given is in great excess of the binding capacity of the serum albumin, the dye concentration in the blood would primarily be related to the serum albumin concentration and not to capillary permeability.
The role which HSF may play in permeability is far from being clear, however. The uptake of 14C-glucose into certain tissues and its disappearance from the blood seem to be influenced by B. pertussis treatment (58; C. W. Fishel and K. F. Keller, Federation Proc. 27:267, 1968 ). The serum concentration of insulin is increased (A. Gulbenkian, personal communication), indicating that permeability of tissues to glucose is increased as a result of this increase in insulin (12) . The serum concentration of dextrans (molecular weight > 80,000) administered to HSF-treated and untreated mice is somewhat analogous to the situation with Evans blue dye; HSF-treated mice always have a lower serum concentration of dextran than do the control mice (R. K. Bergman, unpublished data).
Some experiments also indicate that a change in the intercellular substance may occur after HSF treatment, because carbon particles diffuse more widely from an intracutaneous inoculation site in pertussis-treated animals than in untreated mice (189) . A similar phenomenon has been observed in B. pertussis-treated rats (40) .
Presently, we are inclined to believe that the HSF may in some way block the mouse's normal protective responses to vascular changes produced by histamine or serotonin and perhaps other vasoactive substances (70) . Thus, while these agents may initiate important changes in the capillary permeability of both normal or pertussis-treated mice, the effects may be fatal only in HSF-treated mice, because they cannot make the necessary vascular compensations to sustain life (see also 20, 158) . It has also been observed that, in HSF-treated mice, intracutaneous injection of histamine or serotonin, or VOL. 32, 1968 both, produces a greater permeability change than in normal mice, as judged by Evans blue dye accumulation at the site of injection (R. K. Bergman, unpublished data).
MECHANISM OF AcmION OF HSF FROM B. PERT USSIS
A number of hypotheses on the mechanism of action of HSF have been advanced based on experimental observations. The most important of these are presented below. It should be noted that the phenomenon of histamine sensitization does not depend on formation of antibodies to HSF (57) but on other responses still not fully understood.
One possible mode of action of HSF is that it interferes with the mechanism of destruction of histamine. This view is supported by the demonstration that histaminase activity in tissues of animals treated with pertussis vaccine is reduced (105, 134, 135, (173) (174) (175) (176) . The postulated role of depressed histaminase levels has been questioned, however, because: (i) the main mechanism of detoxifying histamine in the mouse is methylation (220), (ii) animals like the guinea pig, which do not normally become sensitive to histamine, also show a decrease in histaminase activity when treated with pertussis vaccine, and (iii) a decrease in histaminase would not explain the more generalized sensitivity of the mouse to various agents (serotonin, peptone, anaphylaxis, cold stress, X rays, etc.). For these reasons, this hypothesis does not explain the mode of action of HSF.
Another hypothesis attempts to explain the mechanism of HSF as a result of an increased production of histidine decarboxylase which, by its action on histidine, produces histamine. It was thought that this would increase the level of free histamine in the tissues and make the mouse more susceptible to exogenously administered histamine. Histidine decarboxylase is increased in mice treated with pertussis vaccine (222) , but this increase occurs equally in mice that become sensitive to histamine and in mice that do not (222) . Endotoxins of gram-negative bacteria also increase the level of the enzyme without producing marked sensitivity to histamine (221, 222) , and recently it has been found that HSF preparations free of endotoxin do not increase histidine decarboxylase (A. Szentivanyi (41) recently found that injection of cyclic 3', 5'-adenosine phosphate (3', 5'-AMP) and 5'-adenosine phosphate (5'-AMP) elicited hyperglycemia in CFW mice, and that mice that had received 5'-AMP became hypersensitive to histamine, but 3',5'-AMP did not influence histamine sensitivity. These observations at the cellular level may well be related to the phenomenon of histamine sensitization by HSF.
The hypothesis that HSF changes permeability of capillaries and perhaps of tissues in general is still attractive (151) , but further work is needed to assess its importance.
As stated above, some workers believe that the hypoglycemia produced by B. pertussis vaccines is responsible for the hypersensitivity phenomena (71) . This may well be true for some forms of sensitivities, such as the dextran anaphylactoid edema (2, 3, 4, 5, 6, 18, 68, 69, 230, 231) , but probably not for the histamine sensitization produced by HSF. In our hands, small doses of insulin which produce a marked hypoglycemia fail to induce histamine sensitization in mice (R. K. Bergman and J. Munoz, in preparation), and large doses of glucose or other monosaccharides fail to protect HSF-treated mice from histamine (58; Bergman and Munoz, in preparation). In addition, the time course of hypoglycemia does not correspond to that of histamine sensitivity (Bergman and Munoz, in preparation), and a short-term diabetogenic agent (D-mannoheptulose) does not protect HSF-treated mice from histamine challenge. The lack of relationship between hypoglycemia and histamine sensitivity in mice has also been noticed by Cronholm and Fishel (to be published). Thus, it is evident that hypoglycemia per se does not explain histamine sensitization.
A possible role of the reticuloendothelial system (RES) in histamine sensitivity of B. pertussis-treated mice is suggested by the observation that RES "blockade" by colloidal particles protects mice against the effects of serotonin (241; 0. H. Granley, Bacteriol. Proc., p. 88, 1960) . The manner by which blockade of the RES protects mice is not clear, but perhaps it is related to a depressed release from certain cells of substances that elicit or enhance the shock syndrome.
Some years ago, it was noted that adrenalectomy makes mice more sensitive to histamine, serotonin, cold stress, anaphylaxis, endotoxin shock, and other noxae (34, 78, 151, 167 13:507, 1954 ). The similarities between B. pertussis-treated mice and adrenalectomized mice are striking, but one exception has been recorded, in which adrenalectomy did not make mice more sensitive to histamine, whereas B. pertussis vaccine did (66) . It was first throught that HSF acts in some way on the adrenal gland, but the histological appearance of the glands is not changed (120) , and adrenal function does not seem to be affected by B. pertussis treatment (34, 100, 102, 120) . A decrease in ascorbic acid content has been reported (192) , however, and evidence of stress has been seen histologically (171) . Adrenal steroids, such as cortisone and hydrocortisone, protect against histamine challenge, but the amount of these hormones required is from 1 to 4 mg per mouse (36, 95 The proposed importance of the steroid hormones in histamine sensitization diminished when it was observed that adrenal-demedullated mice are hypersensitive to histamine and that small doses (5 to 7.5 gg) of epinephrine given to HSFtreated mice 30 sec after challenge protects them from histamine death (21, 22) . The doses of epinephrine required to protect adrenalectomized or adrenal-demedullated mice are lower than those required to protect HSF-treated normal mice. Thus, it appears that HSF somehow blocks the action of catecholamines. There also seems to be a quantitative relationship between amount of HSF employed and amount of epinephrine needed for protection (22) . The work of Fishel and co-workers (58-60) strongly indicates that B. pertussis affects the function of epinephrine. They found that /3-adrenergic blocking agents (DCI, pronethalol, propranolol) can produce histamine sensitivity in mice and that HSF blocks the hyperglycemic effect of epinephrine. Moreover, they showed that the altered pattern of glucose metabolism, which is elicited by HSF in mice, is duplicated in many respects by (3- adrenergic blocking agents. From their data, there is little doubt that HSF interferes with glucose metabolism and that this effect is similar in many respects to that of 3-adrenergic blockade. Therefore, they proposed that B. pertussis cells either possess a ,B-adrenergic blocking substance or cause the animal to elaborate a substance with steric configuration complementary to the 3-adrenergic receptors (60) . In either case, the site normally available for the adrenergic transmitter (adrenaline and/or noradrenaline) would be blocked. When such animals are challenged with histamine or serotonin, the antagonistic effect of endogenously released catecholamines is, according to this view, blocked at the (3-receptor level, leaving the a-adrenergic activities unopposed. This results in an imbalanced response of the receptors, thus producing unfavorable metabolic adjustments, as well as smooth muscle and neural responses that culminated in a reduced resistance to histamine and serotonin (60) .
The effect of 3-adrenergic blockade on histamine sensitivity has been confirmed (22, 233) . However, we do not agree with the suggestion that death is due to an "imbalance" in the reactivity of the a-and 3-receptors (25) . It is possible that 3-adrenergic blockade may produce a condition whereby epinephrine is incapable of protecting against the shock syndrome elicited by histamine or other noxae. Mice should then become more sensitive to any condition in which the vascular bed is affected and changes in permeability and blood volume are involved. This indeed seems to be the case. It is also unlikely that HSF stimulates the production of a ,Badrenergic blocking substance by the mouse, since passive sensitization by means of serum has not been achieved. Moreover, a normal mouse joined by parabiosis to a sensitized mouse does not become sensitive to histamine (35) . It is more likely that HSF itself is the substance that produces the adrenergic blockade.
CONCLUDING REMARKS
The substances that have been found to sensitize mice to histamine are HSF from B. pertussis and endotoxins from gram-negative bacteria. Of these, only HSF from B. pertussis (and perhaps Brucella abortus) seem to produce a primary sensitization to histamine. Endotoxins (and other toxins, such as that of Pasteurella pestis) seem to produce sensitivity to histamine as a result of their intrinsic toxicity, which nonspecifically sensitizes the animal to other noxious agents. This view seems reasonable on the following grounds: the amount of endotoxin required borders on the lethal dose; "sensitization" is not easily reproduced; a dose-response curve is not observed; and the mortality rate is usually low. HSF from B. pertussis, on the other hand, acts in VOL. 32, 1968 minute amounts (1 to 5 ,ug) without obviously stressing the animal; the response is dose-dependent, and sensitization is uniform and reproducible when test conditions are standardized. The B. pertussis effect seems thus to be a true primary effect. Sensitivity appears to be due to a direct blocking effect on a mechanism normally capable of counteracting the shock effects of histamine, serotonin, anaphylaxis, peptone, endotoxin, etc. This mechanism appears to be associated mainly with the adrenal medullary hormone, epinephrine. This has become increasingly clear through the work of Fishel and coworkers (58-60, 92, 228) as well as our own (21, 22, 25) . HSF does not seem to interfere with production of adrenal hormones but rather to prevent the normal action of epinephrine by "blocking" the f3-adrenergic receptors needed for some of the activities of epinephrine. Much support was given to this view when Fishel and co-workers showed that fl-adrenergic blocking agents mimic the effect of HSF and that HSF produces many metabolic disturbances associated with 3-adrenergic activity (58-60, 92, 228, 233) . If HSF actually blocks the f-adrenergic receptors, this blocking effect must be long lasting, and as a result it may produce many other modifications in the animal. Thus, it is not surprising that many enzyme systems and physiological functions are changed in HSF-treated animals. In this regard, however, it should always be kept in mind that most studies have been carried out with B. pertussis whole cells or with complex extracts from these cells, containing substances with pronounced biological activities, such as endotoxin and heat-labile toxin. Relatively pure HSF, however, has other activities besides producing the increased susceptibility to various types of shock. Thus, highly purified preparations of HSF have the following activities: they induce protection of mice against intracerebral challenge with virulent B. pertussis cells (161); they induce leukocytosis (C. Clausen, unpublished data); they promote antibody production to other antigens given with it (155); they accelerate the induction of EAE; and they change the type of disease produced to a hyperacute type of EAE (113) (114) (115) . Moreover, these purified preparations produce many of the physiological changes reported to be produced by whole cell vaccines (hypoglycemia, increased insulin in blood, etc.) (R. K. Bergman 
